semaglutide 2.0 mg approval Novo Nordisk's weight-loss pill wins FDA Canada approves generic Ozempic semaglutide

We understand that cost is a significant consideration for our patients

But as much as you may know about GLP-1s, theres probably a good amount you probably dont know

Below are eight companies worth considering, starting with the provider that stands out for accessibility, physician-guided care, and overall value

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances

Important safety information : Semaglutide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)